mRNA Platform Market Research Report 2023 - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F
01 déc. 2023 06h18 HE
|
Research and Markets
Dublin, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The "mRNA Platform Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to ResearchAndMarkets.com's...
Dyadic Attends Investor Events in December
30 nov. 2023 08h30 HE
|
Dyadic International, Inc.
Dyadic Attends Investor Events in December
20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer to Expedite mRNA Vaccine Delivery Platform Program
29 nov. 2023 03h00 HE
|
20MED Therapeutics B.V.
Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo Fry as Chief Business Officer. His appointment...
Vaxcyte Appoints Jacks Lee to Board of Directors
28 nov. 2023 08h30 HE
|
Vaxcyte, Inc.
SAN CARLOS, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of...
FLUCELVAX QUADRIVALENT Drug Insights and Market Forecasts, 2032: Focus on United States, Germany, France, Italy, Spain and the United Kingdom
28 nov. 2023 08h08 HE
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "FLUCELVAX QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
[Latest Research 2023], Vaccines Market Size to Surpass USD 125.49 Billion by 2028 | With 10.8% CAGR
28 nov. 2023 05h47 HE
|
Fortune Business Insights
Pune, India, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Global Vaccines Market Size was valued at USD 55.44 billion in 2020 and is projected to grow from USD 125.49 billion by 2028 exhibiting a CAGR of 10.8%...
Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
27 nov. 2023 16h00 HE
|
Vaxcyte, Inc.
-- Vaxcyte Obtains Exclusive Rights to Independently Develop and Manufacture Cell-Free Extract, a Key Component of the Company’s Pneumococcal Conjugate Vaccine (PCV) Franchise -- -- Manufacturing...
North America Digital Vaccine Markets, Competition, Forecast & Opportunities Report 2023-2028 Featuring Friendslearn, Klein Buendel, Evidation Health, Atos, and oVRcome
27 nov. 2023 07h18 HE
|
Research and Markets
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "North America Digital Vaccine Market, Competition, Forecast & Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
Fluzone Quadrivalent Drug Insights and Market Forecasts, 2019-2022 & 2023-2032
24 nov. 2023 09h08 HE
|
Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers...
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
20 nov. 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...